10 March 2027
FDA PDUFA target action date for lonvoguran ziclumeran (lonvo-z), a BLA from Intellia Therapeutics. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
FDA PDUFA Decision Dates calendar